About MannKind

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.

In addition, MannKind is applying our novel technologies and services to support partner development efforts. More >

 

 

Spotlight

Sanofi and MannKind  Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 
More >

News & Events

   
Aug 11, 2014 MannKind Corporation Reports 2014 Second Quarter Financial Results More >
Aug 11, 2014 Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human)... More >
Aug 05, 2014 MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call... More >